| Structure | Chemical Name | CAS | MF |
|
1,1'-dithiobis(2-amino-3-(4-(carboxymethyl)cyclohexyl)propane) bis(trifluoroacetate)
|
156143-99-6
|
|
|
2-(CHLOROMETHYL)-6-FLUORO-1H-BENZO[D]IMIDAZOLE
|
156144-42-2
|
C8H6ClFN2
|
|
1H-1,3a,6-Triazacyclohepta[de]naphthalene,2,3,4,5-tetrahydro-(9CI)
|
156144-61-5
|
C11H13N3
|
|
TETRAKIS(METHYLISOBUTYLKETOXIMINO)SILANE
|
156145-62-9
|
C24H48N4O4Si
|
|
4-Methyl-2-pentanone, O, O′, O′′-(ethenyl silylidyne) trioxime
|
156145-64-1
|
C20H39N3O3Si
|
|
4-Methyl-2-pentanone, O, O′-(methyl vinyl silylene) dioxime
|
156145-66-3
|
C15H30N2O2Si
|
|
Bicyclo[3.1.0]hexan-3-one, 2-(1-hydroxyethylidene)-6,6-dimethyl-, (1S,5R)-
|
156145-74-3
|
C10H14O2
|
|
(hepta(methacryloxyethoxy))(2,4,6-tribromophenoxy)cyclotetraphosphazene
|
156147-85-2
|
C48H65Br3N4O22P4
|
|
SODIUM PHENOLATE TRIHYDRATE
|
156150-40-2
|
C6H11NaO4
|
|
3-CHLORO-4-FLUOROIODOBENZENE
|
156150-67-3
|
C6H3ClFI
|
|
6,7,8-Indolizinetriol, 1-fluorooctahydro-, 1S-(1.alpha.,6.beta.,7.alpha.,8.beta.,8a.beta.)-
|
156150-82-2
|
C8H14FNO3
|
|
1,6,7-Indolizinetriol, 8-fluorooctahydro-, 1S-(1.alpha.,6.beta.,7.alpha.,8.beta.,8a.beta.)-
|
156150-83-3
|
C8H14FNO3
|
|
1,6,8-Indolizinetriol, 7-fluorooctahydro-, 1S-(1.alpha.,6.beta.,7.beta.,8.beta.,8a.beta.)-
|
156150-84-4
|
C8H14FNO3
|
|
Propanoic acid, 2,2-dimethyl-, octahydro-7,8-dihydroxy-1,6-indolizinediyl ester, 1S-(1.alpha.,6.beta.,7.alpha.,8.beta.,8a.beta.)-
|
156150-85-5
|
C18H31NO6
|
|
Propanoic acid, 2,2-dimethyl-, octahydro-6,7,8-trihydroxy-1-indolizinyl ester, 1S-(1.alpha.,6.beta.,7.alpha.,8.beta.,8a.beta.)-
|
156150-86-6
|
C13H23NO5
|
|
Propanoic acid, 2,2-dimethyl-, octahydro-6,7,8-tris(methoxymethoxy)-1-indolizinyl ester, 1S-(1.alpha.,6.beta.,7.alpha.,8.beta.,8a.beta.)-
|
156150-87-7
|
C19H35NO8
|
|
1-Indolizinol, octahydro-6,7,8-tris(methoxymethoxy)-, 1R-(1.alpha.,6.alpha.,7.beta.,8.alpha.,8a.alpha.)-
|
156150-88-8
|
C14H27NO7
|
|
8-Indolizinol, octahydro-1,6,7-tris(phenylmethoxy)-, 1S-(1.alpha.,6.beta.,7.alpha.,8.beta.,8a.beta.)-
|
156150-89-9
|
C29H33NO4
|
|
Indolizine, 8-fluorooctahydro-1,6,7-tris(phenylmethoxy)-, 1S-(1.alpha.,6.beta.,7.alpha.,8.beta.,8a.beta.)-
|
156150-90-2
|
C29H32FNO3
|
|
Indolizine, 8-fluorooctahydro-1,2,7-tris(phenylmethoxy)-, 1S-(1.alpha.,2.beta.,7.alpha.,8.alpha.,8a.alpha.)-
|
156150-91-3
|
C29H32FNO3
|
|
1,6,7,8-Indolizinetetrol, octahydro-, 1,6,8-triacetate, 1S-(1.alpha.,6.beta.,7.alpha.,8.beta.,8a.beta.)-
|
156150-92-4
|
C14H21NO7
|
|
Methanesulfonic acid, trifluoro-, 1,6,8-tris(acetyloxy)octahydro-7-indolizinyl ester, 1S-(1.alpha.,6.beta.,7.alpha.,8.beta.,8a.beta.)-
|
156150-93-5
|
C15H20F3NO9S
|
|
1,6,8-Indolizinetriol, 7-fluorooctahydro-, triacetate (ester), 1S-(1.alpha.,6.beta.,7.beta.,8.beta.,8a.beta.)-
|
156150-94-6
|
|
|
6-Hydroxy-1-phenylnaphthalene
|
156152-21-5
|
C16H12O
|
|
POLYGLYCERYL-2 CAPRATE
|
156153-06-9
|
C16H32O6
|
|
DBD-COCL
|
156153-43-4
|
C11H13ClN4O4S
|
|
1,4-Benzodioxin, piperazine deriv.
|
156154-10-8
|
|
|
Losartan-hydrochlorothiazide mixture
|
156154-37-9
|
C29H30Cl2KN9O5S2
|
|
1,4-Benzodioxin, piperazine deriv.
|
156154-38-0
|
C24H29N5O8S
|
|
Octakis(anilino)octakis(phenylthio)vanadyl phthalocyanine
|
156158-64-4
|
C128H88N16OS8V
|
|
Lys-γ3-MSH
|
156159-18-1
|
C128H193N45O39S
|
|
BQ-788
|
156161-89-6
|
C34H52N5NaO7
|
|
asimin
|
156162-01-5
|
C37H66O7
|
|
Maackiaflavanone
|
156162-10-6
|
C26H30O6
|
|
IN-F 7321
|
156162-13-9
|
C13H12F2OSi
|
|
AC-LYS-ILE-PHE-MET-LYS-NH2
|
156162-44-6
|
C34H58N8O6S
|
|
thiolupinine
|
156171-03-8
|
C10H19NS
|
|
N-[3-(2-AMINO-THIAZOL-4-YL)-PHENYL]-ACETAMIDE
|
156171-61-8
|
C11H11N3OS
|
|
1H-Pyrrolo[1,2-c]imidazol-1-one,hexahydro-(9CI)
|
156171-62-9
|
C6H10N2O
|
|
1H-Pyrrolo[1,2-c]imidazol-1-one,hexahydro-3,3-dimethyl-(9CI)
|
156171-63-0
|
C8H14N2O
|
|
1H-Pyrrolo[1,2-c]imidazol-1-one,3-cyclopropylhexahydro-(9CI)
|
156171-64-1
|
C9H14N2O
|
|
Hexahydro-pyrrolo[1,2-c]iMidazole
|
156171-65-2
|
C6H12N2
|
|
1H-Pyrrolo[1,2-c]imidazole,hexahydro-3-methyl-(9CI)
|
156171-66-3
|
C7H14N2
|
|
1H,3H-Imidazo[1,5-c]thiazole,tetrahydro-(9CI)
|
156171-69-6
|
C5H10N2S
|
|
2-CBZ-AMINO-4-METHYLPENT-2-ENOIC ACID METHYL ESTER
|
156174-28-6
|
C15H19NO4
|
|
2-amino-4-(4-nitrophenyl)-5-oxo-5,6,7,8-tetrahydro-4H-chromene-3-carbonitrile
|
156176-90-8
|
C16H13N3O4
|
|
2-amino-4-(3-chlorophenyl)-5-oxo-5,6,7,8-tetrahydro-4H-chromene-3-carbonitrile
|
156176-91-9
|
C16H13ClN2O2
|
|
3,9-bis((ethylthio)methyl)-K-252a
|
156177-65-0
|
C33H33N3O5S2
|
|
TERT-BUTYL 4-(3-HYDROXYPROPYL)TETRAHYDRO-1(2H)-PYRIDINECARBOXYLATE
|
156185-63-6
|
C13H25NO3
|
|
3-Amino-(2S)-phenylsulfonylaminopropionicacid
|
156185-88-5
|
C9H12N2O4S
|
|
Hispidulin 7-O-neohesperidoside
|
156186-00-4
|
C28H32O15
|
|
1,10-DICHLOROPERFLUORODECANE
|
156186-28-6
|
C10Cl2F20
|
|
3-CHLORO-5-[[(ETHOXYCARBONYL)AMINO]SULFONYL]-1-METHYL-1H-PYRAZOLE-4-CARBOXYLIC ACID, ETHYL ESTER
|
156186-57-1
|
C10H14ClN3O6S
|
|
Z-LEU-ARG-7-AMINO-4-METHYLCOUMARIN
|
156192-32-4
|
C30H38N6O6
|
|
6,7,8-Indolizinetriol, 1-fluorooctahydro-, 1R-(1.alpha.,6.alpha.,7.beta.,8.alpha.,8a.alpha.)-
|
156198-81-1
|
C8H14FNO3
|
|
1-Indolizinol, octahydro-6,7,8-tris(methoxymethoxy)-, 1S-(1.alpha.,6.beta.,7.alpha.,8.beta.,8a.beta.)-
|
156198-82-2
|
C14H27NO7
|
|
3-ethenyl-2,7,12,18-tetramethyl-8-(2-oxoethylidene)-21H,23H-porphine-13,17-dipropanoic acid
|
156198-96-8
|
C35H37N5O6
|
|
asiminacin
|
156199-51-8
|
C37H66O7
|
|
1,6,7,8-Indolizinetetrol, octahydro-, 1,7,8-triacetate, 1S-(1.alpha.,6.beta.,7.alpha.,8.beta.,8a.beta.)-
|
156205-42-4
|
C14H21NO7
|
|
Carbonic acid, octahydro-1,7,8-trihydroxy-6-indolizinyl phenylmethyl ester, 1S-(1.alpha.,6.beta.,7.alpha.,8.beta.,8a.beta.)-
|
156205-43-5
|
C16H21NO6
|
|
Carbonic acid, phenylmethyl 1,7,8-tris(acetyloxy)octahydro-6-indolizinyl ester, 1S-(1.alpha.,6.beta.,7.alpha.,8.beta.,8a.beta.)-
|
156205-44-6
|
C22H27NO9
|
|
1,7,8-Indolizinetriol, 6-fluorooctahydro-, triacetate (ester), 1S-(1.alpha.,6.beta.,7.alpha.,8.beta.,8a.beta.)-
|
156205-45-7
|
C14H20FNO6
|
|
1H-Pyrrolizine-1,2,7-triol, 3-(fluoromethyl)hexahydro-, triacetate (ester), 1R-(1.alpha.,2.beta.,3.alpha.,7.beta.,7a.alpha.)-
|
156205-46-8
|
C14H20FNO6
|
|
1H-Pyrrolizine-1,2,7-triol, 3-(fluoromethyl)hexahydro-, 1R-(1.alpha.,2.beta.,3.alpha.,7.beta.,7a.alpha.)-
|
156205-47-9
|
C8H14FNO3
|
|
1,6,7,8-Indolizinetetrol, octahydro-, 1,7,8-triacetate 6-methanesulfonate, 1S-(1.alpha.,6.beta.,7.alpha.,8.beta.,8a.beta.)-
|
156205-48-0
|
C15H23NO9S
|
|
1,7,8-Indolizinetriol, 6-azidooctahydro-, triacetate (ester), 1S-(1.alpha.,6.beta.,7.alpha.,8.beta.,8a.beta.)-
|
156205-49-1
|
C14H20N4O6
|
|
1H-Pyrrolizine-1,2,7-triol, 3-(azidomethyl)hexahydro-, triacetate (ester), 1R-(1.alpha.,2.beta.,3.alpha.,7.beta.,7a.alpha.)-
|
156205-50-4
|
|
|
1,7,8-Indolizinetriol, 6-aminooctahydro-, triacetate (ester), 1S-(1.alpha.,6.beta.,7.alpha.,8.beta.,8a.beta.)-
|
156205-51-5
|
C14H22N2O6
|
|
1,7,8-Indolizinetriol, 6-aminooctahydro-, 1S-(1.alpha.,6.beta.,7.alpha.,8.beta.,8a.beta.)-
|
156205-52-6
|
C8H16N2O3
|
|
Acetamide, N-1,7,8-tris(acetyloxy)octahydro-6-indolizinyl-, 1S-(1.alpha.,6.beta.,7.alpha.,8.beta.,8a.beta.)-
|
156205-53-7
|
C16H24N2O7
|
|
Acetamide, N-1,7-bis(acetyloxy)hexahydro-2-hydroxy-1H-pyrrolizin-3-ylmethyl-, 1R-(1.alpha.,2.beta.,3.alpha.,7.beta.,7a.alpha.)-
|
156205-54-8
|
C14H22N2O6
|
|
Acetamide, N-(hexahydro-1,2,7-trihydroxy-1H-pyrrolizin-3-yl)methyl-, 1R-(1.alpha.,2.beta.,3.alpha.,7.beta.,7a.alpha.)-
|
156205-55-9
|
C10H18N2O4
|
|
1,7,8-Indolizinetriol, 6-chlorooctahydro-, triacetate (ester), 1S-(1.alpha.,6.beta.,7.alpha.,8.beta.,8a.beta.)-
|
156205-56-0
|
C14H20ClNO6
|
|
1,7,8-Indolizinetriol, 6-bromooctahydro-, triacetate (ester), 1S-(1.alpha.,6.beta.,7.alpha.,8.beta.,8a.beta.)-
|
156205-57-1
|
C14H20BrNO6
|
|
1,7,8-Indolizinetriol, 6-chlorooctahydro-, 1S-(1.alpha.,6.beta.,7.alpha.,8.beta.,8a.beta.)-
|
156205-58-2
|
C8H14ClNO3
|
|
6-Indolizinecarbonitrile, octahydro-1,7,8-trihydroxy-, 1S-(1.alpha.,6.beta.,7.alpha.,8.beta.,8a.beta.)-
|
156205-59-3
|
C9H14N2O3
|
|
1H-Pyrrolizine-3-acetonitrile, hexahydro-1,2,7-trihydroxy-, 1R-(1.alpha.,2.beta.,3.alpha.,7.beta.,7a.alpha.)-
|
156205-60-6
|
C9H14N2O3
|
|
Oxirenofindolizine-6,7-diol, octahydro-, 1aR-(1a.alpha.,6.beta.,6a.alpha.,7.alpha.,7a.alpha.)-
|
156205-61-7
|
C8H13NO3
|
|
1,6,7,8-Indolizinetetrol, octahydro-, 1,7,8-triacetate 6-formate, 1S-(1.alpha.,6.beta.,7.alpha.,8.beta.,8a.beta.)-
|
156205-62-8
|
C15H21NO8
|
|
1H-Pyrrolizine-1,2,7-triol, 3-(formyloxy)methylhexahydro-, triacetate (ester), 1R-(1.alpha.,2.beta.,3.alpha.,7.beta.,7a.alpha.)-
|
156205-63-9
|
C15H21NO8
|
|
1H-Pyrrolizine-1,2,7-triol, hexahydro-3-(hydroxymethyl)-, 1,2,7-triacetate, 1R-(1.alpha.,2.beta.,3.alpha.,7.beta.,7a.alpha.)-
|
156205-64-0
|
C14H21NO7
|
|
.beta.-D-Glucopyranoside, 1,2,7-tris(acetyloxy)hexahydro-1H-pyrrolizin-3-ylmethyl, 2,3,4,6-tetraacetate, 1R-(1.alpha.,2.beta.,3.alpha.,7.beta.,7a.alpha.)-
|
156205-65-1
|
C28H39NO16
|
|
.beta.-D-Glucopyranoside, (hexahydro-1,2,7-trihydroxy-1H-pyrrolizin-3-yl)methyl, 1R-(1.alpha.,2.beta.,3.alpha.,7.beta.,7a.alpha.)-
|
156205-66-2
|
C14H25NO9
|
|
Methanesulfonic acid, trifluoro-, 1,7,8-tris(acetyloxy)octahydro-6-indolizinyl ester, 1S-(1.alpha.,6.beta.,7.alpha.,8.beta.,8a.beta.)-
|
156205-67-3
|
C15H20F3NO9S
|
|
1,7,8-Indolizinetriol, octahydro-6-(phenylmethoxy)-, triacetate (ester), 1S-(1.alpha.,6.beta.,7.alpha.,8.beta.,8a.beta.)-
|
156205-68-4
|
C21H27NO7
|
|
1H-Pyrrolizine-1,2,7-triol, hexahydro-3-(phenylmethoxy)methyl-, triacetate (ester), 1R-(1.alpha.,2.beta.,3.alpha.,7.beta.,7a.alpha.)-
|
156205-69-5
|
C21H27NO7
|
|
1,7,8-Indolizinetriol, octahydro-6-(phenylmethoxy)-, 1S-(1.alpha.,6.beta.,7.alpha.,8.beta.,8a.beta.)-
|
156205-70-8
|
C15H21NO4
|
|
1,7,8-Indolizinetriol, octahydro-6-methoxy-, 1S-(1.alpha.,6.beta.,7.alpha.,8.beta.,8a.beta.)-
|
156205-71-9
|
C9H17NO4
|
|
1,7,8-Indolizinetriol, octahydro-6-(methylamino)-, 1S-(1.alpha.,6.beta.,7.alpha.,8.beta.,8a.beta.)-
|
156205-72-0
|
C9H18N2O3
|
|
1,7,8-Indolizinetriol, octahydro-6-(2-propenylamino)-, 1S-(1.alpha.,6.beta.,7.alpha.,8.beta.,8a.beta.)-
|
156205-73-1
|
C11H20N2O3
|
|
1H-Pyrrolizine-1,2,7-triol, hexahydro-3-(2-propenylamino)methyl-, 1R-(1.alpha.,2.beta.,3.alpha.,7.beta.,7a.alpha.)-
|
156205-74-2
|
C11H20N2O3
|
|
1,7,8-Indolizinetriol, 6-(butylamino)octahydro-, 1S-(1.alpha.,6.beta.,7.alpha.,8.beta.,8a.beta.)-
|
156205-75-3
|
C12H24N2O3
|
|
1H-Pyrrolizine-1,2,7-triol, 3-(butylamino)methylhexahydro-, 1R-(1.alpha.,2.beta.,3.alpha.,7.beta.,7a.alpha.)-
|
156205-76-4
|
C12H24N2O3
|
|
1,7,8-Indolizinetriol, octahydro-6-(2-methylpropyl)amino-, 1S-(1.alpha.,6.beta.,7.alpha.,8.beta.,8a.beta.)-
|
156205-77-5
|
C12H24N2O3
|
|
1H-Pyrrolizine-1,2,7-triol, hexahydro-3-(2-methylpropyl)aminomethyl-, 1R-(1.alpha.,2.beta.,3.alpha.,7.beta.,7a.alpha.)-
|
156205-78-6
|
C12H24N2O3
|
|
1,7,8-Indolizinetriol, octahydro-6-(1-methylpropyl)amino-
|
156205-79-7
|
C12H24N2O3
|
|
1H-Pyrrolizine-1,2,7-triol, hexahydro-3-(1-methylpropyl)aminomethyl-
|
156205-80-0
|
C12H24N2O3
|
|
1,7,8-Indolizinetriol, octahydro-6-(1-methylbutyl)amino-
|
156205-81-1
|
C13H26N2O3
|
|
1H-Pyrrolizine-1,2,7-triol, hexahydro-3-(1-methylbutyl)aminomethyl-
|
156205-82-2
|
C13H26N2O3
|
|
1,7,8-Indolizinetriol, octahydro-6-(2-methoxyethyl)amino-, 1S-(1.alpha.,6.beta.,7.alpha.,8.beta.,8a.beta.)-
|
156205-83-3
|
C11H22N2O4
|